HYBRID EVENT: You can participate in person at Orlando, Florida, USA or Virtually from your home or work.
Pathophysiology and Progression of Diabetes

The intricate mechanisms underlying pathophysiology and progression of diabetes involve a complex interplay of genetic, metabolic, and immune factors. Type 1 diabetes results from autoimmune destruction of pancreatic beta cells, leading to absolute insulin deficiency, whereas type 2 diabetes is primarily driven by insulin resistance and progressive beta-cell dysfunction. Chronic hyperglycemia induces oxidative stress and inflammation, accelerating vascular and neural complications. Key signaling pathways, such as those involving insulin receptor substrates and glucose transporters, play crucial roles in disease development. Recent studies highlight the impact of gut microbiota, mitochondrial dysfunction, and lipid metabolism on diabetes progression. Understanding these molecular and cellular alterations is vital for developing targeted therapies aimed at preserving beta-cell function, enhancing insulin sensitivity, and preventing long-term complications.

Committee Members
Speaker at Diabetes and Endocrinology 2025 - Yong Xiao Wang

Yong Xiao Wang

Albany Medical Center, United States
Speaker at Diabetes and Endocrinology 2025 - F Buck Willis

F Buck Willis

IUHS School of Medicine, Saint Kitts and Nevis
Speaker at Diabetes and Endocrinology 2025 - Gretchen Holmes

Gretchen Holmes

Memorial Hospital at Gulfport, United States
Diabetes 2025 Speakers
Speaker at Diabetes and Endocrinology 2025 - Sujith Rajan

Sujith Rajan

NYU Long Island School of Medicine, United States
Speaker at Diabetes and Endocrinology 2025 - Amy Gutman

Amy Gutman

AdventHealth; Tough Love MD, United States
Speaker at Diabetes and Endocrinology 2025 - Paraskevi Theofilou

Paraskevi Theofilou

Hellenic Open University, Greece
Speaker at Diabetes and Endocrinology 2025 - Clifford Morris

Clifford Morris

Kihealth, United States
Tags

Submit your abstract Today

Watsapp